Companies / Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

Nasdaq: OTLKCIK 1649989ISELIN, NJ
Insider flow · last 90 daysNet buys $178.7K

Financials · FY2025

Revenue$1.41M
Net income$-62.42M
Total debt$967.11M
Cash$7.75M
Diluted EPS$-1.79
Shares outstanding120.9M

Ownership

120.9M shares outstanding · as of May 12, 2026
0.36%Insiders
Ownership
Insiders0.36%429,248
Institutions7.76%9,374,933
Public float91.89%111,059,071

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
0.35%423,655
<0.01%5,593

Institutional holders 57

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$2.01M+1.3M
+312.46%
1,668,579
1.38% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$599.0K+377K
+230.96%
539,802
0.45% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
ExitCommon Stock$-471.6K-298K
-100.00%
0
low
Q1 2026
as of
Millennium Management LLC
13F manager
ExitCommon Stock$-259.9K-164K
-100.00%
0
low
Q2 2026
as of
LPL Financial LLC
13F manager
AddCommon Stock$259.4K+163K
+748.59%
184,942
0.15% of shares
low
Q2 2026
as of
Deutsche Bank AG
13F manager
NewCommon Stock$207.8K+131K
130,700
0.11% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon Stock$-143.3K-90K
-99.86%
128
<0.01% of shares
low
Q1 2026
as of
Scotia Capital Inc.
13F manager
ExitCommon Stock$-116.9K-74K
-100.00%
0
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Sphera Funds Management Ltd.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
OTLKCommon StockEquity69012T305BBG00469JRJ5